Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001193125-26-470277

President and CEO sold 48,202 shares at $16.13 ($777,498)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Sanjiv · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-19 Sale : show line 1 in the form 10b5-1 −48,202 $16.13 $777,498 423,099 D
Open-market sales · 48,202 sh · avg $16.13 · $777,498
Loading xslF345X06/ownership.xml…